Green synthesis of zanthoxylum rhetsa (roxb.) DC. mediated iron oxide nanoparticles with physicochemical characterisations and in vitro biomedical applications Authors: Sumangal S. Kale, Ajay P. Nikum, Vijay L. Gurav, Ghanasham B. Sathe Published: 2026 ABSTRACT A sustainable and eco-friendly approach was developed for the green synthesis of iron oxide nanoparticles (ZR-FeONPs) using the aqueous leaf extract of Zanthoxylum rhetsa (Roxb.) DC., where phytochemicals served as reducing and stabilizing agents. UV-Visible spectroscopy revealed a characteristic absorption peak at 275 nm, while FTIR analysis showed distinct bands (593.57–441.40 cm-1) corresponding to Fe-O vibrations confirming nanoparticle formation. XRD analysis established the crystalline hematite-phase Fe2O3 with an average crystallite size of 17.87 nm. Morphological studies using FEG-SEM and TEM demonstrated quasi-spherical, polydisperse particles with an average size of ~38–40 nm. EDX analysis confirmed elemental composition dominated by Fe (67.7 wt %) and O (29.5 wt %). The nanoparticles exhibited moderate colloidal stability (-24 mV) and superparamagnetic behavior with a saturation magnetization of 47 emu/g. Biological evaluations revealed significant antibacterial (18-22 mm) and moderate antifungal (13–15 mm) activities. The nanoparticles also showed dose-dependent antioxidant (51.81%, IC = 58.19 µg/mL), anti-inflammatory (52.32%, IC50= 95.62 µg/mL) and antidiabetic (56.32%, IC50= 82.34 µg/mL) properties. Additionally, moderate anti-tuberculosis activity (50.23% at 1000 µg/mL) and notable anticancer effects (44.32% inhibition against MCF-7 cells) were observed. Cytotoxicity studies indicated high biocompatibility, with >84% viability in L929 cells. Overall, this study highlights Z. rhetsa (Roxb.) DC. as an effective and underexplored bioresource for synthesizing multifunctional, biocompatible magnetic nanoparticles with promising applications in nanomedicine and therapeutic development.Graphical abstract The graphical abstract illustrates the green synthesis of iron oxide nanoparticles using Zanthoxylum rhetsa (Roxb.) DC. leaf extract, wherein the phytoconstituents function as both reducing and stabilizing agents to convert iron precursor salts into stable nanoparticles. The process of bio-reduction and subsequent capping is represented through cyclic pathways leading to the formation of well-defined iron oxide nanoparticles. Detailed characterization using multiple analytical techniques confirms their structural, morphological, elemental, surface and magnetic properties. Furthermore, the synthesized nanoparticles are evaluated for diverse invitro biomedical applications highlighting their considerable potential in the field of nanomedicine. Introduction Nanotechnology has revolutionized the field of materials science through the incorporation of extremely small particles typically ranging from 1 to 100 nanometers which significantly influence material design and properties. This rapidly developing field is multidisciplinary in nature and encompasses a wide range of applications including bioactivity, energy storage, agriculture and environmental remediation [1]. Nanosized particles have attracted significant attention due to their wide range of applications, ease of synthesis, and ability to undergo surface modification. This category includes various transition metals (d-block elements) which exhibit diverse functionalities and are widely applied in magnetic separation, targeted drug delivery, medical imaging and cancer therapy [2, 3]. Iron oxide nanoparticles (FeONPs) are particularly valued for their superparamagnetic properties which make them highly suitable for applications such as magnetic resonance imaging (MRI), magnetically guided drug delivery and cancer hyperthermia therapy [4]. Their environmentally friendly nature and redox-active properties also make them effective for the removal of pollutants including heavy metals and hazardous organic compounds [5]. However, conventional synthesis methods for FeONPs such as co-precipitation, sol-gel and thermal decomposition [6] often involve toxic chemicals, high energy requirements and the generation of hazardous by-products. These limitations restrict their applicability particularly in biomedical and environmentally sensitive applications[7]. To overcome these limitations, green synthesis has emerged as a safer and more sustainable alternative. This eco-friendly approach utilizes biological systems, including microbes, algae, fungi and plants, for the synthesis of nanoparticles [8, 9]. Plant-based synthesis is particularly advantageous due to its simplicity, scalability and abundance of phytochemicals that facilitate both the reduction and stabilization of metal nanoparticles. Bioactive compounds such as flavonoids, alkaloids and terpenoids play a crucial role in converting metal ions into nanoparticles and stabilizing them, thereby preventing aggregation [10]. Plant extracts are rich in bioactive secondary metabolites, including phenolics, alkaloids, flavonoids, tannins, saponins and proteins. These compounds facilitate the reduction of metal ions into nanoparticles while simultaneously preventing agglomeration resulting in stable and functional nanostructures [11]. Furthermore, water-based (aqueous) extraction methods enhance biocompatibility by avoiding the use of harmful solvents and adhering to the principles of green chemistry. The literature reports the successful biosynthesis of FeONPs using various medicinal plants. Sargassum muticum has been widely studied for its strong reducing properties [12]. Other plants such as Camellia sinensis (green tea) [13] and Lawsonia inermis [14] have also demonstrated similar efficacy in reducing Fe3+ ions to iron oxide nanoparticles, with promising antimicrobial and biomedical applications. Biosynthesized iron oxide nanoparticles (FeONPs) have demonstrated significant antimicrobial activity against a wide range of bacterial and fungal strains [15–17]. In addition, FeONPs exhibit notable antioxidant properties by scavenging free radicals such as DPPH and inhibiting lipid peroxidation, which is beneficial in mitigating oxidative stress related conditions including cancer and neurodegenerative disorders [18]. Owing to their superparamagnetic behavior and biocompatibility, FeONPs also find extensive biomedical applications including targeted drug delivery, tissue regeneration, diagnostic imaging and wound healing where magnetic guidance enhances therapeutic precision [19, 20]. Although Indian Ayurveda encompasses a vast array of medicinal plants many species with significant traditional therapeutic value remain underexplored particularly in the field of nanoscience. Zanthoxylum rhetsa (Roxb.) DC., commonly known as “Indian prickly ash” or “Tirfal,” is widely used in Ayurveda and folk medicine for the treatment of infections, inflammation, toothache, fever and digestive disorders [21, 22]. Its rich phytochemical profile includes bioactive compounds such as berberine, flavonoids, lignans, tannins and essential oils, which are known to exhibit antioxidant, antimicrobial and anti-inflammatory activities [23, 24]. Despite its rich phytochemical composition Zanthoxylum rhetsa (Roxb.) DC. has been scarcely explored for nanoparticle synthesis, with only limited studies reporting the formation of silver [25] and gold nanoparticles [26]. Its potential for the green synthesis of iron-based nanoparticles remains largely untapped, representing a promising research opportunity. The green synthesis mechanism generally involves the phytochemical-mediated reduction of metal ions (e.g., Fe3+→Fe2+) followed by nucleation and subsequent growth of nanoparticles. Bioactive constituents such as polyphenols, proteins and other capping agents play a crucial role in stabilizing the nanoparticles, regulating their size and morphology and preventing aggregation [27–29]. The present study aims to develop an eco-friendly and sustainable approach for the synthesis of iron oxide nanoparticles using phytochemicals derived from Zanthoxylum rhetsa (Roxb.) DC. as reducing and stabilizing agents. It further seeks to address existing research gaps by exploring the potential of this medicinal plant in the green synthesis of iron-based nanoparticles and evaluating their suitability for biomedical applications. By integrating the principles of phytochemistry, nanotechnology and sustainable chemistry this work intends to contribute to the development of biocompatible and environmentally benign nanomaterials. Materials and methods Ferric chloride hexahydrate (FeCl3.6H2O) purchased from Sigma Aldrich and used as received, Zanthoxylum rhetsa (Roxb.) DC. leaf extract, Whatman filter paper No. 41 and Distilled water. All cell line were used for invitro studies was purchased from National Centre for Cell Science, Savitribai Phule Pune University Campus Ganeshkhind Road, Pune - 411007. Maharashtra State, India Collection of plant samples Fresh plant specimens of Zanthoxylum rhetsa (Roxb.) DC. were collected from Satarda village (15.7586° N, 73.8007° E) in Sawantwadi, Sindhudurg district, Maharashtra, India. The collected material was thoroughly washed with tap water followed by distilled water to remove adhering dust and surface impurities. The plant was taxonomically identified and authenticated by Prof. Dr. U. L. Dethe a recognized botanist, taxonomist and Head of the Department of Botany at S.P.K. Mahavidyalaya, Sawantwadi, Maharashtra, India. A voucher specimen (No. 6-R/682/2025; SSK01) was prepared and deposited for future reference. Preparation of plant extract Freshly collected Zanthoxylum rhetsa (Roxb.) DC. leaves were properly washed and dried in the shade at room temperature to preserve their natural components. Then grind into fine powder using an electric grinder. 5 g of Zanthoxylum rhetsa (Roxb.) DC. leaves powder was mixed with 100 cm3 of distilled water and boiled for one hour to make an extract. After cooling, the solution was filtered through Whatman filter paper No. 41. This extract was stored at 04°C in glass bottle for further use. Green synthesis of ZR-FeONPs For this green synthesis, 50 mL of Zanthoxylum rhetsa (Roxb.) DC. leaf extract was mixed with 50 mL of 0.1 M ferric chloride hexahydrate solution (FeCl3.6H2O). The mixture was swirled at 2000 rpm for 8 h using a magnetic stirrer (Remi model number 5 ML). Color change to deep black confirmed the formation of ZR-FeONPs. The formed nanoparticles were collected by centrifugation, washed several times with distilled water, then dried in a hot air oven at 80°C. It was calcinated in a muffle furnace at 550°C. The yield of synthesised nanoparticle found to be approximately 5%. Prepared ZR-FeONPs used for further characterisation and various bio-medicinal applications. The synthesis scheme is represented as below. Characterisation techniques for ZR-FeONPs The average crystallite size of ZR-FeONPs was evaluated using an XRD-Ultra IV diffractometer (Rigaku Corporation, Japan) and calculated through the Scherrer formula, D = 0.9λ/βcos θ. Optical characteristics were analyzed by UV-Vis spectroscopy over the 200-800 nm wavelength range with a resolution of 1 nm using a Shimadzu UV-1800 spectrophotometer (Japan). Functional groups responsible for nanoparticle stabilization were identified using FTIR spectroscopy (Bruker Alpha II, USA) within the 4000-400 cm-1 region. Surface morphology and structural attributes were examined through FEG-SEM using a QUANTA 200 instrument (Netherlands). Elemental composition was determined with an integrated EDX detector attached to the same instrument at an accelerating voltage of 20 keV. Particle size was further assessed using a Tecnai 12 G2 TEM operated at 20-120 kV. The surface charge and colloidal stability were measured using a laser Doppler electrophoresis-based SZ-100V2 Zeta Potential analyser (Horiba, Japan). Magnetic properties were investigated at room temperature using a CryoMagTech CMT-60 VSM across a magnetic field range of −10,000 to +10,000 Oe. In vitro bio medicinal applications of ZR-FeONPs Antibacterial activity The assessment of antibacterial efficiency of ZR-FeONPs was done through the agar-well diffusion method. Under this method, a nutrient agar medium was formulated using peptone, NaCl agar and distilled water. The medium was autoclaved to sterilized. These media were transferred in sterile Petri plate sand were left to set. Using sterile L shaped rod, bacterial strains were inoculated on the media which included Gram positive (Bacillus cereus ATCC 14579, Staphylococcus aureus ATCC 29213) and Gram negative (Escherichia coli ATCC 25922, Proteus vulgaris ATCC 8427) rods. Later, four wells were punched with sterile borer and volumes of ZR-FeONPs (100 μL) were added to the plate. The values are taken as means of triplicate sets. Streptomycin antibiotic was used as a standard control for the comparison. Plates were incubated at 37°C for 24 h. The zone of inhibition was then calculated with the help of a millimetre scale [30, 31]. Antifungal activity The antifungal effectiveness of ZR-FeONPs was investigated against the fungal strains Candida albicans ATCC 10231 and Aspergillus niger ATCC 1015 using a modified Saubroad agar (Hi Media) diffusion technique. To achieve this, Peptone agar medium was created and sterilized in an autoclave. The medium was then transferred into sterile Petri dishes and permitted to solidify. The spore suspension of the fungus was applied to the PDA agar plate. Boreholes were utilized to establish four wells. Amounts of ZR-FeONPs (100 μL) were placed in the wells of the Petri dish and incubated at 27°C for 24 h. The experiment was conducted using three identical sets of values. The area of inhibition surrounding the wells was measured in millimetres [30, 31]. Antioxidant activity The scavenging activity of synthesized ZR-FeONPs was estimated using 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical by the scavenging method [32]. The reaction mixture included 1 mL of respected samples of different concentrations with 1.5 mL of 0.1% DPPH radical solution prepared in methanol and incubated further for 30 min. in dark. The absorbance of the mixture was recorded at 510 nm using a spectrophotometer (UV-1800, Shimadzu, Japan). The ability to scavenge the DPPH radical was calculated using the following Eq. 1,1\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$ \% {\rm{inhibition}}=\frac{{\rm{Ac}}-{\rm{As}}}{{\rm{Ac}}}\times 100$$\end{document}% inhibition=Ac−AsAc×100Where, Ac= Absorbance of control, As= Absorbance of sample. Anti-inflammatory activity In vitro anti-inflammatory activity by Protein denaturation method [33]. The reaction mixture (10 mL) contained 0.4 mL of fresh hen’s egg albumin, 5.6 mL of phosphate buffered saline (PBS, pH 6.4) and 100 μL of different concentration samples. A comparable volume of double-distilled water was utilized as a control. Incubate the combinations at 37°C ±2 for 15 min, then heat to 70°C for 5 min. After cooling, absorbance was measured at 660 nm using double distilled water as a blank. The absorbance was determined using diclofenac sodium as a reference which was prepared identically. The percentage inhibition of protein denaturation was calculated by using the following Eq. 2,2\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$ \% {\rm{inhibition}}=\frac{{\rm{Ac}}-{\rm{At}}}{{\rm{Ac}}}\times 100$$\end{document}% inhibition=Ac−AtAc×100Where, Ac = absorbance of control At = absorbance of test sample Antidiabetic activity In vitro alpha amylase inhibition was studied [34, 35]. In brief, 100 μL of varied doses of ZR-FeONPs test compound was allowed to react with 500 μL of 0.1 M phosphate buffer pH 6.9 with α-amylase enzyme (fungal diastase (0.5%)). After a 10 min incubation at 25°C, 500 μL of 1% starch in 0.1 M phosphate buffer (pH 6.8) was added. Incubate at 25°C for 10 min. The controls involved replacing 500 μL of the enzyme with buffer. Following incubation 1000 μL of dinitro salicylic acid reagent was added to both control and test samples. They were maintained in a boiling water bath for 10 min before cooling. The absorbance was measured at 540 nm using a spectrophotometer and the % inhibition of the α-amylase enzyme was calculated using Eq. 3,3\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$ \% \,{\rm{inhibition}}=\frac{{\rm{Abs}}540\left({\rm{control}}\right)-{\rm{Abs}}540({\rm{sample}})}{{\rm{Abs}}540\left({\rm{control}}\right)}\times 100$$\end{document}%inhibition=Abs540control−Abs540(sample)Abs540control×100 Anti-TB activity In vitro Anti-TB Assay was done by using Mycobacterium tuberculosis H37Ra (ATCC 25177) strain [36]. Mycobacterium tuberculosis H37Ra (ATCC 25177) was grown to mid-log phase reaching an optical density (OD) of 0.6 (about 5 × 107 CFU/mL) at 600 nm. Each well of a 96-well microplate received 100 microliters (5 × 104 CFUs) of bacterial suspension. Next, 10 μM of the chemical was applied to each well. DMSO was utilized as the negative control, whereas rifampicin (RIF) was employed as the positive. The plates were sealed and incubated at 37°C for 6 days. Each well received a 10% (v/v) solution of Alamar Blue. Each compound anti-Mtb action was assessed by its color change. The color change from blue to pink indicated that the chemical was active against Mtb. The absorbance of the plate was measured at 600 nm using a microplate reader. Percentage inhibition was given by Eq. 4,4\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$ \% {\rm{Inhibition}}=\frac{{\rm{OD}}\left({\rm{control}}\right)-{\rm{OD}}({\rm{sample}})}{{\rm{OD}}\left({\rm{control}}\right)}\times 100$$\end{document}% Inhibition=ODcontrol−OD(sample)ODcontrol×100Where, OD= Optical Density. Anticancer activity MCF-7, a human breast cancer cell line, was employed. The cell line was cultured in Dulbecco’s modified Eagle’s medium (Gibco) supplemented with 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin (Gibco) in an incubator at 37°C. To cultivate cells using trypsin-EDTA conventional trypsinization was used [37–39]. The cell viability study utilized the MTT assay to evaluate the effects of ZR-FeONPs on MCF-7 cells. MCF-7 cells were incubated at a concentration of 1 × 104 cells/mL in culture medium for 24 h at 37°C with 5% CO2. Various concentrations of ZR-FeONPs were added to the cells with control wells containing DMSO. After incubation, MTT reagent was added and the cells were further incubated to allow for formazan crystal formation, indicating viable cells. Replicate this three times to get accurate results. The absorbance of the samples was then measured at 550 nm to assess cell viability. The percentage inhibition and IC50 values of ZR-FeONPs and positive control were determined through standard Eq. 5,5\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\, \% {\rm{Inhibition}}=\frac{{\rm{OD}}\left({\rm{control}}\right)-{\rm{OD}}({\rm{sample}})}{{\rm{OD}}\left({\rm{control}}\right)}\times 100$$\end{document}% Inhibition=ODcontrol−OD(sample)ODcontrol×100 Cytotoxicity activity MTT L929 normal fibroblast cell line was used, which were incubated at a concentration of 1 × 104 cells/mL for 24 h at 37°C and 5% CO2. Cells were seeded in 96-well microplates with varying sample concentrations (20-100 µg/mL) and control wells with DMSO. Following incubation, MTT reagent was added and the cells were cultured for an additional 04 h to allow for formazan crystal growth. The media was then replaced with DMSO and the samples were incubated again before measuring absorbance at 550 nm to determine cell viability. To guarantee that the results were correct the experiment was repeated three times [37–39].The cytotoxicity was calculated using the Eq. 6,6\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\, \% {\rm{Inhibition}}=\frac{{\rm{OD}}\left({\rm{control}}\right)-{\rm{OD}}({\rm{sample}})}{{\rm{OD}}\left({\rm{control}}\right)}\times 100$$\end{document}% Inhibition=ODcontrol−OD(sample)ODcontrol×100 Results and discussion Characterisation of green synthesised ZR-FeONPs X-ray diffraction (XRD) XRD pattern of the synthesized ZR-FeONPs reveals the diffraction peaks observed at 2θ values at 24.120, 33.138, 35.599, 40.817, 49.468, 54.085, 62.508 and 64.033 respectively, as indicated by their indices of the (012), (104), (104), (113), (024), (116), (214) and (300) crystal planes respectively shown in Fig. 1. These peaks align with the standard JCPDS card No. 89-8104 [40], confirming the formation of rhombohedral hematite-phase Fe2O3 structure with potential incorporation of Fe ions enhancing stability and altering crystallinity with average crystallite size 17.87 nm. The sharp and intense diffraction peaks suggest a high degree of crystallinity and purity of the nanoparticles. The absence of any additional impurity peaks further validates the successful synthesis via phytochemical constituents in plant extracts, which act as reducing and stabilizing agents. Several studies have confirmed that plant-mediated synthesis of iron oxide nanoparticles (FeONPs) results in nanocrystals with similar structural characteristics. For instance, Platanus orientalis for FeONPs synthesis, reporting comparable peak intensities and lattice planes [41], effective crystalline nature shown by using Fraxinus chinensis [42], Albizia adianthifolia extract also showed reflections matching hematite phases, confirming the role of plant phenolics and flavonoids in nucleating uniform crystals [15] respectively. Peltophorum pterocarpum reporting enhanced crystallinity and magnetic properties similar to what is observed in this study [43]. Overall, the XRD pattern supports the successful green synthesis of ZR-FeONPs with good crystallite nature and phase purity, suitable for various biomedical and environmental applications.Fig. 1XRD peaks of ZR-FeONPs XRD peaks of ZR-FeONPs Ultraviolet-Visible Spectroscopy (UV-Vis) The UV-Visible absorption spectrum of the green-synthesized ZR-FeONPs exhibits a distinct peak at 275 nm, as shown in Fig. 2, which is characteristic of Fe2+-O2- charge transfer transitions and confirms the formation of iron-based nanoparticles. The pronounced absorption in this ultraviolet region may also be attributed to the presence of surface-bound bioactive phytochemicals including phenolics, flavonoids, terpenoids and alkaloids derived from the plant extract which contribute to both stabilization and optical properties of the nanoparticles. Unlike noble metal nanoparticles such as gold and silver, iron oxide nanoparticles do not typically exhibit a distinct Surface Plasmon Resonance (SPR) band in the visible region due to their non-metallic nature and different electronic structure. In the present study, the absorption peak observed at approximately 275 nm is attributed to Fe2+-O2- charge transfer transitions along with contributions from phytochemical constituents of the plant extract. The absence of any characteristic absorption peak in the visible region (400-800 nm) confirms the lack of SPR behavior, which is consistent with previously reported studies on plant-mediated iron oxide nanoparticles. For instance where plant extracts such as Cistus monspeliensis [44], Laurus nobilis [45], Fraxinus chinensis [42], Glycosmis mauritiana [46], Calotropis procera [47] were employed to synthesize iron oxide nanoparticles with UV-Vis absorbance maxima in the 230-280 nm region confirming bio-assisted nanoparticle formation. The stability and intensity of the absorption peak also support the effective stabilization of nanoparticles results affirm that ZR-FeONPs were successfully synthesized using a plant-mediated eco-friendly route and their UV-Vis profile aligns well with previously reported green-synthesized iron oxide nanomaterials.Fig. 2UV-Visible absorption spectrum of ZR-FeONPs UV-Visible absorption spectrum of ZR-FeONPs Fourier transform infrared spectroscopy (FTIR) The FTIR spectrum of the green-synthesized ZR-FeONPs reveals distinct peaks that confirm both the formation of FeONPs and the involvement of plant-based functional groups in their reduction and stabilization. A broad absorption band observed around 3415.24 cm-1 corresponds to O-H stretching vibrations of hydroxyl groups indicating the presence of alcohols and phenolic compounds from the plant extract, which act as natural reducing agents. The peak at 2920.94 cm-1 is attributed to C-H stretching of aliphatic -CH2 groups, typically from organic plant molecules. A peak at 1614.50 cm-1 corresponds to C = C stretching, suggesting the presence of aromatic. The absorption at Peaks observed in the range 600-400 cm-1 particularly near 593.57, 538.49, 471.06 and 441.40 cm-1 are characteristic of Fe-O stretching vibrations, confirming the successful formation of iron oxide nanoparticles as shown in Fig. 3. These spectral features align with prior studies using Glycosmis mauritiana [46], Calotropis procera [47], pine tree needles [48], Azardirachta Indica [49] where FTIR analysis similarly confirmed the participation of polyphenolic and proteinaceous compounds from plant extracts in nanoparticle formation and surface capping. Thus, the FTIR spectrum supports that ZR-FeONPs were synthesized through a green route where plant phytoconstituents acted both as reducing and stabilizing agents ensuring biocompatibility and functional surface chemistry.Fig. 3FTIR analysis of ZR-FeONPs FTIR analysis of ZR-FeONPs Field Emission Gun-Scanning Electron Microscopy (FEG-SEM) FEG-SEM images synthesized of ZR-FeONPs provide valuable insights into their surface morphology and microstructural features. At higher magnification (Fig. 4. i.e. a) and b) which shows 10000× and 4,000×) the nanoparticles appear as aggregated clusters with irregular morphology and a rough surface texture. It indicates partial agglomeration which is commonly reported in green-synthesized nanoparticles due to the presence of bioorganic stabilizing agents derived from plant extracts. These capping agents i.e. secondary metabolites contribute to the particle formation but can also promote partial aggregation during drying and imaging as noted in FeONPs synthesized using Calotropis procera [50] and aloe vera [51] extracts. Lower magnification images (Fig. 4. i.e. c) and d) respectively 1,000× and 500×) show flake-like larger structures intermixed with fine particles suggesting the presence of a heterogeneous mixture of nano and micro-scale fragments possibly arising from plant metabolites or unreacted precursors. Similar morphologies have been observed in FeONPs synthesized from Calotropis procera [47] and Ruellia tuberosa [52] where the nanoparticle surfaces were coated with organic matter from the extract, contributing to bio-functional surface properties. Thorough and porous nature of the particles as evident in the FEG-SEM images is advantageous for catalytic, antimicrobial and environmental applications due to enhanced surface area and reactivity. These morphological features are in line with previous reports where green synthesis led to polydisperse, non-spherical iron oxide nanoparticles with bio-organic coatings, enhancing their stability and biocompatibility [53].Fig. 4FEG-SEM magnification of ZR-FeONPs i.e. a) 10000×, b) 4000×, c) 1000× and d) 500× FEG-SEM magnification of ZR-FeONPs i.e. a) 10000×, b) 4000×, c) 1000× and d) 500× Energy dispersive X-ray analysis (EDX) The Energy Dispersive X-ray Spectroscopy (EDS) analysis of ZR-FeONPs confirms the elemental composition and purity of the nanoparticles. The spectrum and data reveal Fe (67.7 wt%, 38.6 at%) and oxygen (29.5 wt%, 58.9 at%) indicates the formation of iron oxides as show in Fig. 5, predominantly Fe2O3 consistent with prior reports on plant-derived iron oxide nanoparticles [43]. Trace elements like potassium (K), calcium (Ca), sulfur (S), phosphorus (P) and silicon (Si) are also detected, which are typically called as micronutrients in the plant [54]. These trace elements can influence the morphology, stability and biocompatibility of the nanoparticles as previously observed in FeONPs synthesized using Azardirachta Indica [49] studied. The high net intensity values of Fe and O peaks reaffirm the dominance of iron oxide formation and its successful reduction via plant phytochemicals. Ruellia tuberosa [52] and Cicer arietinum [55] respectively reported similar EDS profiles, indicating that phytoconstituents assist not only in reduction but also in elemental stabilization. Thus, this EDS analysis show elemental composition.Fig. 5EDX analysis of ZR-FeONPs EDX analysis of ZR-FeONPs Transmission electron microscopy (TEM) TEM pictures of ZR-FeONPs show polydisperse nanoparticles with quasi-spherical to irregular morphology indicating heterogeneous nucleation and development aided by phytochemicals in the plant extract. The annotated particle sizes range from 16 nm to 71 nm, with the majority grouping around the average size of ~38-40 nm as shown in Fig. 6. The size distribution of iron oxide nanoparticles generated through plant-mediated pathways is directly dependent on secondary metabolites. Some regions in TEM suggests crystalline cores, Fe2O3 enveloped by initial organic shells from plant constituents commonly observed in biosynthesized nanoparticles [56]. Similar morphological features have been reported for FeONPs synthesized using Platanus orientalis [41], Teucrium polium [57] and Artemisia vulgaris [58]. The absence of uniform size favors the green synthesis process in contrast to the monodisperse structures generally generated using chemical or hydrothermal process. The observed particle agglomeration may be due to hydrogen bonding or van der Waals interactions among surface-bound biomolecules akin to findings in studies involving Rosemary extract [59]. In contrast, FEG-SEM analysis shows aggregated, irregular and flake-like clustered structures with rough surface features. This difference arises from surface imaging at comparatively lower resolution and the tendency of biosynthesized nanoparticles to undergo agglomeration during drying. The presence of plant-derived capping agents further promotes interparticle interactions leading to cluster formation. Therefore, the variation is complementary rather than contradictory TEM reflects the true primary nanoparticle morphology whereas FEG-SEM represents the aggregated surface architecture in the solid state.Fig. 6TEM analysis of ZR-FeONPs as in a), b), c) and d) TEM analysis of ZR-FeONPs as in a), b), c) and d) Zeta potential (ZP) The zeta potential analysis of ZR-FeONPs reveals a mean zeta potential of -24.0 mV shown in Fig. 7, indicating moderate colloidal stability due to electrostatic repulsion between the charged particles. This value lying close to the ±30 mV threshold, suggests that the nanoparticles possess a sufficient surface charge to remain well-dispersed in suspension reducing the risk of agglomeration. The surface potential arises from the presence of bioorganic molecules such as amine, hydroxyl and carboxyl groups originating from the plant extract used during synthesis, which serve as both reducing and capping agents. Additionally, the electrophoretic mobility value of -0.000162 cm²/Vs may be influenced by pH, ionic strength or measurement conditions though the net zeta potential value still reflects surface capping by plant derived functional groups. These findings are consistent with previous reports on plant-mediated synthesis of iron oxide nanoparticles using species such as Citrus maxima [60], Ceratonia siliqua [61] and Clitoria ternatea [62] where zeta potential values ranged from -40 to +40 mV depending on the phytochemical profile and synthesis conditions. A zeta potential in this range implies that ZR-FeONPs are moderately stable, suitable for applications in drug delivery, water treatment or antimicrobial formulations where stability in suspension is critical.Fig. 7Zeta Potential analysis of ZR-FeONPs Zeta Potential analysis of ZR-FeONPs Vibrating sample magnetometer (VSM) The room-temperature VSM profile of the ZR-FeONPs exhibited a reproducible S-shaped M-H curve with negligible coercivity and almost zero remanence confirming their superparamagnetic nature. The nanoparticles showed a saturation magnetization (Ms) of 47 emu/g, which is sufficiently high for magnetic guidance and separation yet low enough to avoid residual magnetization after field removal as shown in Fig. 8. Similarly, Gundelia tournefortii [63] leaf extract shows ~48.6 emu/g with near zero coercivity indicating superparamagnetic, 53.32 emu/g shows from Juglansregia phytogenic [64] iron oxide nanoparticles with low coercive forces and minimal hysteresis. In another study Saccharum arundinaceum [65] extract mediated iron oxide nanoparticles displayed 80.58 emu/g further confirming the dominance of superparamagnetic in plant capped FeONPs. The observed soft magnetic behavior of ZR-FeONPs is consistent with other photosynthesized iron oxide nanoparticle systems, where nanoscale dimensions and the presence of organic capping agents disrupt long-range magnetic ordering. This results in a reversible field-dependent magnetization profile making such nanoparticles particularly suitable for diverse biomedical and environmental applications.Fig. 8VSM analysis of ZR-FeONPs VSM analysis of ZR-FeONPs Bio-medicinal applications of ZR-FeONPs Antibacterial activity The ZR-FeONPs demonstrated pronounced antibacterial activity against a diverse range of pathogenic bacteria producing inhibition zones between 18 and 22 mm at the tested concentration which were slightly lower than those observed for the standard antibiotic streptomycin (27–30 mm). Among the evaluated strains, Proteus vulgaris ATCC 8427 exhibited the highest susceptibility with a zone of inhibition of 22 mm, followed by Staphylococcus aureus ATCC 29213 (20 mm), Escherichia coli ATCC 25922 (19 mm) and Bacillus cereus ATCC 14579 (18 mm) as illustrated in Fig. 9 and Table 1. The broad-spectrum antibacterial efficacy of ZR-FeONPs can be primarily attributed to their nanoscale dimensions and high surface-to-volume ratio which facilitate enhanced interaction with microbial cells. These nanoparticles promote the generation of reactive oxygen species (ROS), including hydroxyl radicals (•OH) and superoxide anions (O2 •-) leading to oxidative stress that compromises cell membrane integrity, increases permeability and results in the leakage of intracellular constituents. Furthermore, the Fe²⁺/Fe³⁺ redox cycling triggers Fenton-type reactions, intensifying oxidative damage to essential biomolecules such as proteins, lipids and DNA. In addition, electrostatic interactions between the positively charged nanoparticles and the negatively charged bacterial cell walls contribute to membrane destabilization, structural deformation and eventual bacterial cell death. Similar research using plant-based iron nanoparticles from Moringa oleifera [66], Sida cordifolia [67], Eucalyptus robusta [68] and Zingiber officinale [69] has also shown good antibacterial results. These results further substantiate the role of plant-mediated synthesis in improving the functional performance of nanoparticles. Consequently, ZR-FeONPs emerge as promising natural antibacterial agents, with potential applicability against drug-resistant bacterial strains.Fig. 9Indicates Gram-negative bacteria i.e. (a) E. Coli, (b) Proteus vulgaris and Gram-positive bacteria i.e. (c) B. cereus, (d) S. aureusTable 1Zone inhibition in mm of Antibacterial activityTest pathogensZR-FeONPs (mm) µg/mLStreptomycin (mm) µg/mL E. coli1930P. vulgaris2228B. cereus1827S. aureus2029Standard deviation19.75 ± 1.7128.5 ± 1.29 Indicates Gram-negative bacteria i.e. (a) E. Coli, (b) Proteus vulgaris and Gram-positive bacteria i.e. (c) B. cereus, (d) S. aureus Table 1Zone inhibition in mm of Antibacterial activityTest pathogensZR-FeONPs (mm) µg/mLStreptomycin (mm) µg/mL E. coli1930P. vulgaris2228B. cereus1827S. aureus2029Standard deviation19.75 ± 1.7128.5 ± 1.29 Zone inhibition in mm of Antibacterial activity Antifungal activity The ZR-FeONPs displayed appreciable antifungal activity, with inhibition zones for Candida albicans ATCC 10231 is 15 mm and for Aspergillus niger ATCC 1015 is 13 mm observed against the tested fungal strains as shown in Fig. 10 Table 2. Although these values were comparatively lower than those recorded for the standard streptomycin (24 mm and 25 mm) the results clearly indicate a significant inhibitory effect. This antifungal performance can be attributed to the combined influence of iron oxide nanoparticles and bioactive constituents derived from Zanthoxylum rhetsa (Roxb.) DC. The nanoparticles interact with the fungal cell wall and membrane leading to structural disruption and increased permeability which facilitates deeper penetration into the cell. Concurrently, the generation of reactive oxygen species (ROS) induces oxidative stress, damaging vital intracellular components and impairing essential enzymatic functions. Moreover, the phytochemical capping agents present on the nanoparticle surface are likely to interfere with key metabolic pathways and inhibit spore germination collectively contributing to the suppression of fungal growth. The green synthesis method improves the nanoparticles biocompatibility and stability, as the plant-based capping agents help target fungal cells more effectively compared to chemically made nanoparticles [70]. Similar studies support these results. For example, Mikania mikrantha [71] based FeONPs against Aspergillus niger and Candida species with inhibition zones between 10-20 mm, Albizia amara [72] to be effective against similar fungi . Hibiscus sabdariffa [73] flower extract caused leakage of internal cell contents and structural damage in fungal spores. Altogether, these findings suggest that ZR-FeONPs due to their natural origin, moderate antifungal activity and low toxicity could be useful as a sustainable and safe alternative for antifungal treatments and disinfectants especially for resistant fungal infections.Fig. 10Antifungal activity of (a) Candida albicans and (b) Aspergillus nigerTable 2Antifungal activity zone inhibitionTest pathogensZR-FeONPs (mm) µg/mLStreptomycin (mm) µg/mLCandida albicans1524Aspergillus niger1325Standard deviation14.0 ± 01.0024.5 ± 0.5 Antifungal activity of (a) Candida albicans and (b) Aspergillus niger Table 2Antifungal activity zone inhibitionTest pathogensZR-FeONPs (mm) µg/mLStreptomycin (mm) µg/mLCandida albicans1524Aspergillus niger1325Standard deviation14.0 ± 01.0024.5 ± 0.5 Antifungal activity zone inhibition Antioxidant activity The antioxidant potential of ZR-FeONPs, evaluated using the DPPH free radical scavenging assay, demonstrated a concentration-dependent response, achieving 51.81% inhibition at 100 µg/mL with an IC50 value of 58.19 µg/mL, while the standard ascorbic acid exhibited higher activity 78.23% inhibition at 100 µg/mL and IC50 = 43.53 µg/mL as shown in Figs. 11 and 12. Despite comparatively lower activity, the nanoparticles showed significant free radical scavenging capability, primarily governed by their surface chemistry and redox behavior. The mechanism involves phytochemical residues from Zanthoxylum rhetsa (Roxb.) DC such as phenolics and flavonoids adsorbed on the nanoparticle surface which act as effective electron or hydrogen donors to stabilize DPPH radicals by converting them into non-reactive forms. Simultaneously, the iron oxide core contributes through reversible Fe2+/Fe3+ redox cycling facilitating electron transfer processes that further neutralize reactive species. The combined effect of surface-bound bioactive molecules and the intrinsic redox properties of the nanoparticles enhance their ability to quench free radicals thereby imparting measurable antioxidant activity. Similar outcomes were reported in previous studies where iron oxide nanoparticles made from Vitis vinifera [74], Myrtus communis [75] and Phoenix dactylifera leaves [76] also showed antioxidant properties. Plumeria obtuse [70] based FeONPs gained antioxidant strength from both surface phytochemicals and the redox activity of iron ions which can donate electrons to stabilize free radicals. ZR-FeONPs may serve as natural antioxidants for health supplements, medical treatments and skincare products due to their eco-friendly production.Fig. 11Antioxidant activity of ZR-FeONPsFig. 12Antioxidant assay of ZR-FeONPs by DPPH method Antioxidant activity of ZR-FeONPs Antioxidant assay of ZR-FeONPs by DPPH method Anti-inflammatory activity The in vitro albumin denaturation assay demonstrated that ZR-FeONPs possess moderate yet concentration-dependent anti-inflammatory activity, achieving a maximum inhibition of 52.32% at 100 µg/mL as shown in Fig. 13. Although this response was lower than that of the standard drug diclofenac sodium 81.39% inhibition at 100 µg/mL and IC50 = 46.11 µg/mL compared to an IC50 of 95.62 µg/mL for ZR-FeONPs as shown in Fig. 14. Nanoparticles still exhibited a significant capacity to mitigate protein denaturation and stabilize biomacromolecules under stress conditions. Mechanistically, this effect is largely driven by an enhanced suppression of reactive oxygen species (ROS), including superoxide anions (O2•⁻), hydroxyl radicals (•OH) and hydrogen peroxide (H2O2), thereby limiting oxidative stress–induced activation of inflammatory signalling pathways. Concurrently, phytochemical capping agents derived from Zanthoxylum rhetsa (Roxb.) DC synergistically contribute by modulating key inflammatory enzymes such as cyclooxygenase (COX) and lipoxygenase (LOX), as well as reducing the production of pro-inflammatory mediators. This combined ROS scavenging and enzyme inhibitory action underlies the observed anti-inflammatory efficacy of the nanoparticles. The ability to prevent protein denaturation is an accepted marker for anti-inflammatory potential, since protein breakdown is a key part of inflammation [77]. This activity is likely due to natural compounds in Z. rhetsa (Roxb.) DC. which are known to protect proteins and reduce oxidative stress. Similar results were found in studies using iron nanoparticles made from Vitis vinifera [74], Nigella sativa (black seeds) [78] and Vitex trifolia [79] which also showed anti-inflammatory effects through albumin protection. The iron in nanoparticles may enhance their activity by neutralizing free radicals or affecting inflammation-related enzymes. Although ZR-FeONPs exhibit comparatively moderate efficacy relative to standard anti-inflammatory drugs, their plant-based origin, low toxicity and biocompatibility underscore their potential as natural anti-inflammatory agents. This observation is consistent with current trends in nanomedicine that emphasize the development of plant-derived nanoparticles as safer, sustainable and biologically compatible alternatives for therapeutic applications.Fig. 13Anti-inflammatory activity of ZR-FeONPsFig. 14Anti-inflammatory assay of ZR-FeONPs (a) standard and (b) Sample Anti-inflammatory activity of ZR-FeONPs Anti-inflammatory assay of ZR-FeONPs (a) standard and (b) Sample Antidiabetic activity ZR-FeONPs exhibited moderate antidiabetic activity in the α-amylase inhibition test, demonstrating dose-dependent enzyme inhibition ranging from 5.17% at 20 µg/mL to 56.32% at 100 µg/mL as shown in Fig. 15 which indicating their potential for managing type 2 diabetes. Although less potent than the conventional medication acarbose which achieved 84.48% inhibition at 100 µg/mL with an IC50 of 52.13 µg/mL compared to 82.34 µg/mL for ZR-FeONPs as shown in Fig. 16 the nanoparticles still displayed significant enzyme-inhibiting characteristics. This effect likely arises from the synergistic action of the iron oxide core and natural phytochemicals from Z. rhetsa (Roxb.) DC wherein ZR-FeONPs inhibit α-amylase by interacting with the enzymes active site or altering its conformation thereby reducing starch breakdown into glucose. The surface-bound phytochemicals may enhance this inhibition through hydrogen bonding and hydrophobic interactions with the enzyme, while iron ions may further contribute by influencing glucose metabolism and reducing diabetes associated oxidative stress. Similar research supports these findings. As an example, Sesamum indicum leaf extract showed moderate inhibition of α-amylase and α-glucosidase due to the interaction of plant compounds with the enzymes [80], Mehani had potential to lower blood sugar levels [81]. Iron incorporation into nanoparticles can enhance glucose metabolism and mitigate oxidative stress thereby improving their overall therapeutic efficiency. Although ZR-FeONPs exhibit lower potency compared to conventional antidiabetic drugs their green synthesis, favorable safety profile and inherent biological activity highlight their potential as a sustainable and natural alternative. These attributes make them particularly suitable for long-term management strategies or as supportive agents in the form of dietary supplements for diabetes care.Fig. 15Anti-diabetic activity of ZR-FeONPsFig. 16Antidiabetic activity of ZR-FeONPs by α-amylase assay (a) standard and (b) ZR-FeONPs Anti-diabetic activity of ZR-FeONPs Antidiabetic activity of ZR-FeONPs by α-amylase assay (a) standard and (b) ZR-FeONPs AntiTb activity The in vitro anti-tuberculosis assessment against Mycobacterium tuberculosis H37Ra (ATCC 25177) demonstrated that ZR-FeONPs exhibit modest yet concentration-dependent activity, with minimal inhibition observed at lower doses ranging from 7.8 to 31.2 µg/mL and a gradual increase at higher concentrations, reaching 50.23% inhibition at 1000 µg/mL, as illustrated in Figs. 17 and 18. Although this activity remains lower than that of rifampicin, which demonstrated 71.88% inhibition at 1000 µg/mL, the nanoparticles nonetheless display meaningful anti-mycobacterial potential. This effect can be attributed to a multifaceted mechanism involving enhanced generation of reactive oxygen species (ROS) such as superoxide anions (O2•⁻) and hydroxyl radicals (•OH) which induce oxidative damage to vital cellular components. The nanoscale size facilitates penetration through the lipid-rich, mycolic acid containing cell wall of M. tuberculosis enabling intracellular interactions that disrupt metabolic functions and structural integrity. Simultaneously, iron mediated redox cycling may further amplify oxidative stress, while surface-bound phytoconstituents from Zanthoxylum rhetsa (Roxb.) DC contribute by interfering with key enzymatic systems necessary for mycobacterial survival. Collectively, these combined actions underline the potential of ZR-FeONPs as supportive agents, particularly in strategies aimed at enhancing the efficacy of existing anti-TB therapies.Fig. 17Anti-Tb activity of ZR-FeONPsFig. 18Anti-Tb activity of standard and ZR-FeONPs Anti-Tb activity of ZR-FeONPs Anti-Tb activity of standard and ZR-FeONPs Anticancer activity The MTT assay performed on the MCF-7 breast cancer cell line revealed that ZR-FeONPs exert mild, dose-dependent cytotoxic effects while maintaining relatively high cell viability, with the highest tested concentration of 100 µg/mL inducing 44.32% cell death and leaving 55.68% of cells viable. In contrast, the standard anticancer drug 5-fluorouracil exhibited markedly higher efficacy, reducing cell viability to 16.04% with an IC50 value of 38.12 µg/mL as depicted in Figs. 19 and 20. Notably, ZR-FeONPs did not achieve 50% inhibition within the tested concentration range precluding IC50 determination and indicating comparatively lower toxicity, which may be advantageous for safer therapeutic applications. Mechanistically, the observed cytotoxicity is predominantly associated with oxidative stress–induced apoptosis, wherein elevated levels of reactive oxygen species (ROS) disrupt mitochondrial function, leading to loss of membrane potential and activation of intrinsic apoptotic pathways including caspase cascades. Iron-mediated Fenton reactions further intensify intracellular oxidative damage, promoting DNA fragmentation and potential cell cycle arrest. Additionally, phytochemical constituents adsorbed on the nanoparticle surface may enhance selective interactions with cancer cells contributing to the overall anticancer response. These results align with previous research involving green-synthesized iron nanoparticles from plants like Cinchona officinalis [82] and Euphorbia tirucalli [83] triggered cancer cell death through oxidative stress, mitochondrial damage and apoptosis. Syzygium aromaticum based FeONPs, which selectively affected cancer cells while being less harmful to normal cells [84]. ZR-FeONPs demonstrate a moderate anticancer effect due to the synergistic action of their iron core and bioactive compounds from Z. rhetsa (Roxb.) DC. This indicates that ZR-FeONPs may offer a promising avenue for cancer therapy, particularly in combination treatments or as targeted delivery agents with fewer side effects.Fig. 19Anticancer activity of ZR-FeONPsFig. 20Anticancer activity microscopic images i.e (a) Control, (b) Standard and (c) ZR-FeONPs Anticancer activity of ZR-FeONPs Anticancer activity microscopic images i.e (a) Control, (b) Standard and (c) ZR-FeONPs Cytotoxicity activity The MTT assay on L929 fibroblast cells demonstrated that ZR-FeONPs possess excellent biocompatibility with minimal cytotoxic effects, as indicated by consistently high cell viability ranging from 84.88% to 99.09% and low inhibition values between 0.91% and 15.12% across the tested concentration range of 20-100 µg/mL as shown in Fig. 21, whereas the standard exhibited pronounced toxicity reducing viability to 16.85% at 100 µg/mL with an IC50 of 59.68 µg/mL. Notably, ZR-FeONPs did not achieve 50% inhibition at any tested dose and therefore their IC50 is considered not effective (NE) as illustrated in Fig. 22 confirming their non-toxic nature toward normal cells. This high biocompatibility is mechanistically associated with controlled and limited generation of reactive oxygen species (ROS) which prevents excessive oxidative stress in healthy cells. In addition, phytochemical capping agents derived from Zanthoxylum rhetsa (Roxb.) DC form a stabilizing biomolecular layer on the nanoparticle surface that reduces nonspecific cellular interactions and helps neutralize excess reactive species such as hydroxyl radicals (•OH) and superoxide anions (O2•⁻). As a result, while ZR-FeONPs can still induce ROS-mediated damage in pathogenic or cancerous cells leading to mitochondrial dysfunction and apoptosis this moderated oxidative response in normal cells preserves cellular integrity thereby enabling selective activity with a favourable safety profile. For instance, Pimenta dioica exhibited selective toxicity, supporting their potential in biomedical use [85], Vitex leucoxylon had minimal effects on normal fibroblast cells [86], plant extracts show improved biological safety and stability due to organic surface groups [87]. ZR-FeONPs are biocompatible and non-toxic, making them suitable for medical applications like drug delivery, wound healing and diagnostic imaging.Fig. 21Cytotoxicity analysis of ZR-FeONPsFig. 22Cytotoxic activity images i.e (a) Control, (b) Standard and (c) ZR-FeONPs Cytotoxicity analysis of ZR-FeONPs Cytotoxic activity images i.e (a) Control, (b) Standard and (c) ZR-FeONPs Conclusion This study successfully demonstrates a green, sustainable and efficient approach for the synthesis of iron oxide nanoparticles using Zanthoxylum rhetsa (Roxb.) DC leaf extract (ZR-FeONPs). The UV-Vis absorption band at 275 nm and the FTIR absorption band in the range of 600-400 cm-1 confirm the successful formation of iron oxide nanoparticles. The average crystallite size was found to be 17.87 nm, while the average particle size i.e. ~38–40 nm indicates a quasi-spherical morphology. FEG-SEM data revealed aggregated clusters, while EDX analysis confirmed high purity with dominant Fe and O composition. The nanoparticles exhibited moderate colloidal stability i.e. -24 mV and distinct superparamagnetic behavior with a saturation magnetization of 47 emu/g. Biological investigations highlighted their multifunctional potential demonstrating strong antibacterial activity (18–22 mm) and notable antifungal effects (13–15 mm). Dose-dependent antioxidant (51.81%, IC50 = 58.19 µg/mL), anti-inflammatory (52.32%, IC50 = 95.62 µg/mL) and antidiabetic activities (56.32%, IC50 = 82.34 µg/mL) were observed. Additionally, 50.23% inhibition was observed at 1000 µg/mL for anti-tuberculosis activity, while anticancer activity showed 44.32% inhibition at 100 µg/mL. The nanoparticles also exhibited excellent biocompatibility ( > 84% cell viability), indicating their safety for biomedical applications. Overall, this work establishes Z. rhetsa as a promising and underexplored bioresource for magnetic nanomaterial synthesis. Future studies should focus on in vivo validation, mechanistic insights, toxicity profiling and targeted drug delivery applications to facilitate translation into clinical and industrial use.